Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

May 20-23, 2019
Manchester Grand Hyatt,
San Diego, CA

THE LARGEST MEETING TO ACCELERATE OLIGONUCLEOTIDE AND PEPTIDE PRODUCTS FROM EARLY DISCOVERY TO LATE-STAGE DEVELOPMENT & COMMERCIALIZATION

TIDES Offers the Science, Technologies and Partners You Need to Grow Your Business

1000+ OLIGONUCLEOTIDE AND PEPTIDE SCIENTISTS AND EXECUTIVES

Fast-track your oligonucleotide and peptide research to the clinic and beyond by collaborating with leading pharma, biotechs, academia and solution providers from North America, Asia and Europe.

125+ CASE STUDIES AND NEW DATA PRESENTATIONS

Hear best practices, lessons learned and important industry developments across the entire spectrum of oligonucleotide and peptide development and production.

90+ EXHIBITORS

Connect with leading manufacturing, technologies, and service providers to drive your promising therapeutic towards commercial success.

CALL FOR SPEAKERS

We are now accepting speaking proposals for TIDES 2019.

If you are working in any of the following scientific/business topic areas below, we encourage you to submit a proposal. Deadline is November 16.

  • Preclinical and clinical phase oligos and peptides: case studies
  • Oligo discovery (new modalities, long oligos, aptamers, siRNA, new modifications, new biology)
  • Oligonucleotide manufacturing/CMC (processes, scale-up, improved yield/quality, control)
  • Peptide discovery (generics, new modalities, hybrids, modifications, cocktails, immunotherapies)
  • Peptide manufacturing/CMC (process, analytics, QC, raw materials, supply chain, technology)
  • GLP-1 Landscape: pipeline advances and new delivery approaches
  • Impurity profiling, qualification, control strategies; genotix impurities
  • mRNA or CRISPR Therapeutic Discovery and CMC Strategies, Impurity Profiling
  • Analytics, bioanalysis and control strategies for peptides, oligos, mRNA, CRISPR
  • Personalized medicine-based oligos and peptides; Peptide vaccines, Rare disease strategies
  • Regulatory strategies, experiences and guidances for oligos and peptides, IND/IMPD strategies
  • Green chemistry / Sustainable chemistry/ Environmental sustainability
  • Conjugation strategies (GalNAc, targeting, oligo-peptide conjugates)
  • Novel chemistries and synthesis (chirality, peptide chemistry, optimization, new modifications)
  • Drug Delivery (targeting, carriers, mode of admin., devices, endosomal escape, cell-penetration)
  • Formulation strategies (Lipid nanoparticles, peptide formulations, controlled release)
  • Nonclinical (tox, PK, safety, off-target) development strategies and case studies
  • Drug product development strategies for oligonucleotides and peptides

TIDES 2018 Highlight Video


Hear why our attendees rank TIDES as the #1 meeting to gain the science, technologies and contacts they need to accelerate promising oligonucleotide and peptide products towards commercial success!

cross-fertilize ideas and best practices with researchers from different disciplines

Oligonucleotide Tracks
  • Chemistry, Manufacturing & Controls: Comprehensive CMC, analytical, manufacturing and regulatory strategies for both drug substance and drug product to accelerate oligonucleotide product development.
  • Discovery, Preclinical and Clinical: Design oligonucleotides with better drug-like properties to accelerate your products to the clinic and to market. The latest preclinical and clinical updates to benchmark your research and improve your clinical efforts.
Peptide Tracks
  • Chemistry, Manufacturing & Controls: Improve process efficiencies and overcome challenges in process development, CMC and manufacturing. Understand regulatory expectations, new technologies and alternative approaches for emerging complex molecules.
  • Discovery, Preclinical and Clinical: Explore new frontiers in peptide synthesis, discovery, design and engineering to improve targeting, delivery and drug-like properties. Case studies on the latest preclinical and clinical successes of peptides and peptide-like scaffolds and structures.

TIDES Tube - Watch Past Keynote Presentations


TIDES Tube provides the global oligonucleotide and peptide community with exclusive video content designed to help accelerate promising therapeutics from early discovery to late-stage development & commercialization.

Check out TIDES Tube now to watch video of last year's keynote presentations.

Do you want to highlight your company's expertise in TIDES Tube?  Contact us today!

Connect with Key Buyers at TIDES 2019 in San Diego